Severe Immune Checkpoint Inhibitor Toxicity Leading to ICU Admission in Patients With Solid Tumors

Am J Clin Oncol. 2022 Sep 1;45(9):403-404. doi: 10.1097/COC.0000000000000935. Epub 2022 Aug 26.

Authors

Marine Leprince^{1

2}, Bertrand Pourroy^{2

3}, Mohamed Boucekine^{2

4}, Pascale Tomasini^{2

5

6}, Julien Carvelli^{1

2

6}

Affiliations

¹ AP-HM, Réanimation des Urgences.
² Aix-Marseille University.
³ AP-HM, OncoPharma Unit.
⁴ AP-HM, Timone University Hospital Département de Santé Publique et d'Information Médicale.
⁵ AP-HM, Nord University Hospital Multidisciplinary Oncology & Therapeutic Innovations Department.
⁶ AP-HM, OncoSafety Network, Marseille, France.

PMID: 36044321
DOI: 10.1097/COC.0000000000000935

No abstract available

Publication types

Letter

MeSH terms

Hospitalization
Humans
Immune Checkpoint Inhibitors*
Immunotherapy
Intensive Care Units
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors